Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
05/2008
05/27/2008US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine
05/27/2008US7378413 2-amino-3-(alkyl)-pyrimidone derivatives
05/27/2008US7378404 For therapy of estrogen-deficiency-induced diseases and conditions
05/27/2008US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding
05/27/2008CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors
05/22/2008WO2008021331A3 Oxazolidone derivatives as pr modulators
05/22/2008WO2008017521A3 Compositions with enhanced elasticizing activity
05/22/2008WO2006059913A9 Modulation of ovulation
05/22/2008US20080119546 Treatment of hyperproliferative conditions of body surfaces
05/22/2008US20080119537 5-Aryl indan-1 one and analogs useful as progesterone receptor modulators
05/22/2008US20080119534 Benzimidazole Derivatives as Therapeutic Agents
05/22/2008US20080119512 Carboxamide Derivatives as Therapeutic Agents
05/22/2008US20080119504 aporphine 10- and 11-mono-esters and 10,11-asymmetric di-esters; dopaminergic agonist; Parkinson's disease, hemicrania, restless leg syndrome, sexual dysfunction, hyperprolactemia and psychotic disorders
05/22/2008US20080119484 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
05/22/2008US20080119445 Testing a woman's blood to make sure it includes estradiol within a predetermined range and testosterone within a second predetermined range, then administrating a drug selected from the group consisting of vardenafil hydrochloride and tadalafil prior to sexual activity; dehydroepiandrosterone (DHEA)
05/22/2008US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD)
05/22/2008US20080119394 folliculogenesis and follicular maturation without ovarian hyperstimulation; compositions that contain various amounts of FSH and hCG, as well as various FSH-to-hCG ratios, supplied in a single preparation; enable the practitioner to optimize ovulatory stimulation in flexible manner
05/21/2008EP1923388A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder
05/21/2008EP1922072A2 Melanocortin receptor-specific piperazine compounds with diamine groups
05/21/2008EP1681296B1 Epimeredi glycoside a, the formulation containing thereof and their preparation method
05/21/2008EP1448591B1 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations
05/21/2008EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/21/2008EP1379492B1 Inhibitor of monoamine uptake
05/21/2008EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
05/21/2008EP1265911B1 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
05/21/2008EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use
05/21/2008EP1003545B1 Heparin-binding growth factor (hbgf) polypeptides
05/21/2008DE102006054535A1 Progesteronrezeptorantagonisten Progesterone receptor antagonists
05/21/2008CN101184738A Purified form of tanaproget
05/21/2008CN101181638A Female surface coating contraceptive
05/21/2008CN101181636A Compound vaccine composition for preventing and controlling human viral infection, compound vaccine vaginal mist and uses thereof
05/21/2008CN101181629A Medicament abundantly containing FN for curing cervical erosion gynecopathy
05/21/2008CN101181619A Method for preparing bolus for reinforcing middle-jiao and replenishing qi
05/21/2008CN101181605A Capsule for curing medical postoperative colporrhagia as well as preparation method and mass control method
05/21/2008CN101181599A Chinese medicine composition for curing chronic pelvic inflammatory disease as well as application thereof
05/21/2008CN101181594A Health care beverage for preventing and controlling menorrhalgia
05/21/2008CN101181588A Application of jing-qian-ping particle in the preparation of medicament for curing climacteric syndrome
05/21/2008CN101181585A Chinese medicine for curing infertility
05/21/2008CN101181575A Motherwort strip containing natural aromatic plant
05/21/2008CN101181566A Chinese medicine composition for curing women's syndrome
05/21/2008CN101181512A Medicament for curing vesiculitis as well as preparation technique thereof
05/21/2008CN101181511A Medicament for curing women's yin deficiency spermatozoon immune body resistance as well as preparation technique thereof
05/21/2008CN101181507A Chinese medicine prescription for curing impotency premature ejaculation
05/21/2008CN101181478A Chinese medicine for curing lung cancer and mammary cancer
05/21/2008CN101181473A Compound maytenfolic splinter
05/21/2008CN101181471A Medicament for curing pelvic inflammatory disease and preparation method thereof
05/21/2008CN101181464A Chinese medicine composition for curing women's leukorrhagia
05/21/2008CN101181460A Chinese medicine composition for curing gynecology inflammation and method of making the same
05/21/2008CN101181454A Chinese medicine composition for curing women's redundant menses
05/21/2008CN101181441A Medicament for curing gonad progeria as well as preparation technique thereof
05/21/2008CN101181424A Medicament for curing aberrat menses as well as preparation technique thereof
05/21/2008CN101181423A Mastication tablet for women's climacteric-syndrome-relieving as well as processing method
05/21/2008CN101181409A Chinese medicine composition for curing women's menoxenia
05/21/2008CN101181406A Mass control method of capsule preparations for curing gynecology inflammation
05/21/2008CN101181391A Chinese medicine composition for curing uterine cancer and cervical cancer
05/21/2008CN101181375A Pastille soft capsule and preparation method thereof
05/21/2008CN101181374A Chinese medicine composition as well as preparation technique and application thereof
05/21/2008CN101181367A Chinese medicine for curing menorrhalgia
05/21/2008CN101181361A Penyanjing soft capsule and preparation method thereof
05/21/2008CN101181354A Fructus schizandrae chemical composition group extract and preparation technique
05/21/2008CN101181337A High ester catechin capsule for curing mammary cancer and preparation method thereof
05/21/2008CN101181331A Method for preparing artemisia leaf total chromocor
05/21/2008CN101181329A Total chromocor extract of blumea riparia as well as pharmaceutical composition and preparing method thereof
05/21/2008CN101181326A Notoginsen triterpenes freeze-dried powder pin preparations for injections and preparation method thereof
05/21/2008CN101181307A Proprietary Chinese medicine for curing mastadenitis and breast cancer as well as preparing method
05/21/2008CN101181300A Chinese medicine preparation for curing venereal disease
05/21/2008CN101181288A Solid-state molecule disperse preparations of pennogenin series compounds
05/21/2008CN101181265A Nitric acid butoconazole cyclodextrin or cyclodextrin derivant clathrate and preparation method as well as application thereof
05/21/2008CN101181063A Nutrition health products for curing male infertility and sex hypofunction as well as preparing method thereof
05/21/2008CN100388949C Lysostaphin freeze dried powder used for preventing and treating cattle edometritis
05/21/2008CN100388936C Bolus for treating collateral and gynecological disease
05/21/2008CN100388931C Medicine for treating pelvic inflammation and its preparing method
05/21/2008CN100388930C Quality control method of Xiaoyao preparation
05/20/2008US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods
05/20/2008US7375205 Elongase genes and uses thereof
05/20/2008US7375199 Cancer-associated genes
05/20/2008US7375123 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
05/20/2008US7375109 Glycine-substituted thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
05/20/2008US7375098 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes
05/20/2008US7374891 Receptor for Advanced Glycated Endproducts (RAGE); detecting binding of ligand and protein in presence of peptide, lipid, carbohydrate; amyloid, high-throughput colorimetric assay
05/20/2008CA2432223C Pyrazole compounds useful as protein kinase inhibitors
05/20/2008CA2415681C Pyrrolidine derivatives
05/20/2008CA2333668C 17.beta.-nitro-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties
05/20/2008CA2294480C Microdose therapy of female sexual dysfunction by no, co, and their donors
05/20/2008CA2268886C Aminothiophenecarboxamides
05/15/2008WO2008056687A1 Novel spiropiperidine derivative
05/15/2008WO2008056114A1 Arginase in pregnancy
05/15/2008WO2008037045A3 Composition containing a mixture of antidepressants for treating premature ejaculation.
05/15/2008WO2008035358A3 Process for preparing dapoxetine
05/15/2008WO2008021339A3 Pyrrolidine and related derivatives useful as pr modulators
05/15/2008WO2008001389A3 Female contraceptive for transcervical delivery and its' preparation
05/15/2008US20080114051 Pyrrolidine derivatives as prostaglandin modulators
05/15/2008US20080114018 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
05/15/2008US20080113972 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis
05/15/2008US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use
05/15/2008US20080113953 Administering ethinyl estradiol or prodrug thereof to patient with improved bioavailability by orally administering solid dosage form that releases effective amount of ethinyl estradiol or prodrug thereof in oral cavity for absorption through oral mucosa; for hormone replacement therapy or contraception
05/14/2008EP1921078A1 Multikinase inhibitor
05/14/2008EP1921066A1 Pyridylphenol compound and use thereof
05/14/2008EP1921065A1 Phenylpyridone derivative
05/14/2008EP1920370A2 Drug, drug guidance system, magnetic detection system, and drug design method